Nilotinib BE

nilotinib · KeifeRx, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nilotinib BE, covering 2021-12-03 to 2021-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease [Phase 3]